RALEIGH, NC – Specialty Pharmaceutical Company Mayne Pharma announced on Thursday afternoon that it will expand its business in Greenville where it already has about 350 employees.

Mayne Pharma plans to add 110 jobs and invest $65 million in a new oral dose manufacturing facility and equipment during the next five years. The new positions will include scientists, quality assurance specialists, and manufacturing operators with an average $60,000 per year.

The specialty pharmaceutical company develops and manufactures branded and generic products globally, in addition to providing contract development and manufacturing services. Headquartered in Adelaide, Australia, Mayne Pharma’s $65-million expansion plans include the construction of 126,000 square feet of new FDA-compliant space for use in large-scale oral and solid-dose manufacturing.

The company will receive roughly $2.7 million in tax and other incentives, including a $550,000 grant from the One North Carolina Fund.